Andreas H.
- Country
- Germany
- Department
- Department für Frauengesundheit Universitäts-Frauenklinik
Research Overview
- Comparison of Adjuvant Elacestrant with Standard Endocrine Therapy in High-Risk ER+/HER2- Early Breast Cancer
- Efficacy and Safety of Inavolisib plus Combination Therapy in Patients with Endocrine-Resistant HR+/HER2- Advanced Breast Cancer with Chromosome 8p Loss
- A PHASE III, RANDOMIZED, OPEN-LABEL STUDY EVALUATING THE EFFICACY AND SAFETY OF GIREDESTRANT IN COMBINATION WITH PHESGO VERSUS PHESGO AFTER INDUCTION THERAPY WITH PHESGO+TAXANE IN PATIENTS WITH PREVIOUSLY UNTREATED HER2-POSITIVE, ESTROGEN RECEPTOR-POSITIVE LOCALLY-ADVANCED OR METASTATIC BREAST CANCER
Data & Insights
Has run more than one trial at 334 of 663 partner sites.
Specializations
Breast Cancer Specialization
This investigator demonstrates extensive expertise in breast cancer research, with particular focus on various molecular subtypes including HER2-positive, triple-negative, and hormone receptor-positive disease.
- Early-stage breast cancer interventions
- Neoadjuvant therapy approaches
- Metastatic breast cancer treatment
Their work encompasses innovative therapeutic strategies including targeted therapies and immunotherapy combinations.
Gynecologic Oncology
The investigator has significant involvement in gynecologic cancer research, particularly focusing on advanced ovarian cancer and endometrial cancer treatment strategies.
- First-line treatment optimization
- Targeted therapy combinations
- Post-surgical therapeutic approaches
Their research includes evaluation of novel drug combinations and maintenance therapies.
Precision Medicine
The investigator specializes in biomarker-guided treatment approaches and personalized therapy strategies across various cancer types.
- Molecular profiling applications
- Targeted therapy development
- Dynamic treatment adjustment
Their work incorporates genomic testing and biomarker analysis for treatment optimization.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
